TY - JOUR
T1 - Variation in practice patterns in device closure of atrial septal defects and patent ductus arteriosus
T2 - An analysis of data from the IMproving Pediatric and Adult Congenital Treatment (IMPACT) registry
AU - O'Byrne, Michael L.
AU - Kennedy, Kevin F.
AU - Rome, Jonathan J.
AU - Glatz, Andrew C.
N1 - Funding Information:
Dr. O'Byrne receives research support from the National Institute of Health/National Heart Lung and Blood Institute (K23 HL130420–01). The analysis in this manuscript was funded by the American College of Cardiology and National Cardiovascular Data Registry. The proposed project and manuscript were reviewed by IMPACT Research and Publications Committee. The funding agencies had no role in the drafting of the manuscript or influencing its content. This manuscript represents the opinion of the authors alone.
Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2018/2
Y1 - 2018/2
N2 - Practice variation is a potentially important measure of healthcare quality. The IMPACT registry provides a representative national sample with which to study practice variation in trans-catheter interventions for congenital heart disease. Methods We studied cases for closure of atrial septal defect (ASD) and patent ductus arteriosus (PDA) in IMPACT between January 1, 2011, and September 30, 2015, using hierarchical multivariate models studying (1) the distribution of indications for closure and (2) in patients whose indication for closure was left (LVVO) or right ventricular volume overload (RVVO), the factors influencing probability of closure of a small defect (either in size or in terms of the magnitude of shunt). Results Over the study period, 5233 PDA and 4459 ASD cases were performed at 77 hospitals. The indications for ASD closure were RVVO in 84% and stroke prevention in 13%. Indications for PDA closure were LVVO in 57%, endocarditis prevention in 36%, and pulmonary hypertension in 7%. There was statistically significant variability in indications between hospitals for PDA and ASD procedures (median rate ratio (MRR): 1.3 and 1.1; both P <.001). The proportion of cases for volume overload with a Qp:Qs <1.5:1 decreased with increasing PDA and ASD procedural volume (P =.04 and 0.05). For ASD, the proportion was higher at hospitals with a larger proportion of adult cases (P =.0007). There was significant variation in practice in the risk of closing PDA <2 mm for LVVO (MRR: 1.4, P <.001). Conclusion There is measurable variation in transcatheter closure of PDA and ASD. Further research is necessary to study whether this affects outcomes or resource utilization.
AB - Practice variation is a potentially important measure of healthcare quality. The IMPACT registry provides a representative national sample with which to study practice variation in trans-catheter interventions for congenital heart disease. Methods We studied cases for closure of atrial septal defect (ASD) and patent ductus arteriosus (PDA) in IMPACT between January 1, 2011, and September 30, 2015, using hierarchical multivariate models studying (1) the distribution of indications for closure and (2) in patients whose indication for closure was left (LVVO) or right ventricular volume overload (RVVO), the factors influencing probability of closure of a small defect (either in size or in terms of the magnitude of shunt). Results Over the study period, 5233 PDA and 4459 ASD cases were performed at 77 hospitals. The indications for ASD closure were RVVO in 84% and stroke prevention in 13%. Indications for PDA closure were LVVO in 57%, endocarditis prevention in 36%, and pulmonary hypertension in 7%. There was statistically significant variability in indications between hospitals for PDA and ASD procedures (median rate ratio (MRR): 1.3 and 1.1; both P <.001). The proportion of cases for volume overload with a Qp:Qs <1.5:1 decreased with increasing PDA and ASD procedural volume (P =.04 and 0.05). For ASD, the proportion was higher at hospitals with a larger proportion of adult cases (P =.0007). There was significant variation in practice in the risk of closing PDA <2 mm for LVVO (MRR: 1.4, P <.001). Conclusion There is measurable variation in transcatheter closure of PDA and ASD. Further research is necessary to study whether this affects outcomes or resource utilization.
UR - http://www.scopus.com/inward/record.url?scp=85036530125&partnerID=8YFLogxK
U2 - 10.1016/j.ahj.2017.10.018
DO - 10.1016/j.ahj.2017.10.018
M3 - Article
C2 - 29421004
AN - SCOPUS:85036530125
SN - 0002-8703
VL - 196
SP - 119
EP - 130
JO - American Heart Journal
JF - American Heart Journal
ER -